Temasek Holdings Private Ltd Reduces Position in GE HealthCare Technologies Inc. $GEHC

Temasek Holdings Private Ltd lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,318,290 shares of the company’s stock after selling 12,225 shares during the quarter. Temasek Holdings Private Ltd’s holdings in GE HealthCare Technologies were worth $108,126,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares during the period. Dodge & Cox raised its position in GE HealthCare Technologies by 13.4% during the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after purchasing an additional 3,693,918 shares in the last quarter. Capital Research Global Investors raised its position in GE HealthCare Technologies by 1.6% during the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after purchasing an additional 389,796 shares in the last quarter. State Street Corp raised its position in GE HealthCare Technologies by 2.0% during the 4th quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after purchasing an additional 401,932 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in GE HealthCare Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 12,112,503 shares of the company’s stock valued at $989,673,000 after purchasing an additional 37,159 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on GEHC. BTIG Research decreased their target price on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a research report on Wednesday, April 29th. HSBC decreased their target price on GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Finally, Jefferies Financial Group decreased their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Nine research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $80.21.

GE HealthCare Technologies Stock Down 0.6%

GE HealthCare Technologies stock opened at $64.76 on Tuesday. The business has a fifty day moving average of $66.21 and a two-hundred day moving average of $75.07. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The firm has a market cap of $29.46 billion, a P/E ratio of 15.49, a P/E/G ratio of 1.47 and a beta of 0.74. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Activity at GE HealthCare Technologies

In related news, Director Watkin Phoebe L. Yang bought 1,000 shares of the stock in a transaction on Friday, May 8th. The stock was bought at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the acquisition, the director directly owned 13,702 shares in the company, valued at approximately $863,363.02. This represents a 7.87% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO James Saccaro bought 3,310 shares of the stock in a transaction on Friday, May 1st. The shares were bought at an average price of $60.60 per share, with a total value of $200,586.00. Following the acquisition, the chief financial officer owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought 21,847 shares of company stock valued at $1,361,355 over the last 90 days. Insiders own 0.36% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.